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The crystal structures of seven substituted phenethylammonium salts and one (phenylpropyl)ammonium salt have been determined. (I) Trimethyl(phenethyl)ammonium iodide, C ~HIsN+. M r = 291.2, orthorhombic, P2, 2~2~ (No. 19 ), a = 6.040 (2), b=7-689(2), c=26.528(9) A, V=1232(1)A 3, Z := 4, D_ = 1.56 g cm -3, Mo Ks radiation (2 = 0.71073~), g=25.33cm -~, F(000)=576, T= 298 K, R (wR) = 0.0302 (0.0305)for 1991 reflections with I> 3e(/). (II) (p-Hydroxyphenethyl)trimethylammonium iodide, C~HIsNO÷.I -, Mr=307"2, triclinic, P] (No. 2), a = 9.619 (1), b = 9.926 (1), c =14.179(2)A, a=95.24(1), /~= 97.50 (1), y= 98.97(1) ° , V=1317.2(3)A 3, z=4, Dx= 1.55 gcm -3, Mo K~t radiation (2 = 0.71073 A), /z = 23.79 cm-l, F(000) = 608, T = 298 K, R (wR) = 0.0351 (0.0373) for 4320 reflections with I > 3tr(/). (III) (m-Hydroxyphenethyl)trimethylammonium iodide hemihydrate, C IIHlsNO+.I-.½H20, M r = 316.2, monoclinic, P2~/n (non-standard, No. 14), a = 8.048 (2), b=9.782(3), c= 17.447(7)A, fl=90.15(1) °, V= 1374 (2) A 3, Z = 4, D x = 1-53 g cm -3, Mo Ks radiation (2 = 0-71073 A), /z = 22-86 cm -~, F(000) = 628, T= 298 K, R (wR) = 0.0719 (0.0655) for 1006 reflections with I > l t r(/). (IV) (3,4-Dihydroxyphenethyl)trimethylammonium iodide (coryneine iodide), C ll-HIsNO2+.I -, Mr=323.2, monoclinic, P2, /a (nonstandard, No. 14) , a= 13.144(5), b= 15.676(7), c=6.832(2)A, p= 103.50(3) ° , V= 1369(1)A 3, z = 4, D_ = 1.57 g cm -3, Mo Ka radiation (2 = 0.71073~), /z=22.98cm -~, F(000)=640, T= 298 K, R (wR) = 0.0306 (0.0325) for 1880 reflections with I> 3a(I). (V) 2-Hydroxy-2-phenylethylamine hydroiodide, CsH~2NO+.I -, monoclinic, No. 14) , a= 10.377(5), b= 7.934(4), c=11.957(6)A, fl = 90. 76 (4) °, V= 984 (1) A 3, Z = 4, D x = 1.79 gcm -3, Mo Ks radiation (2 =0.71073 A), a= 31.69 cm-', F(000) = 512, T= 298 K, R (wR) = 0.1022 (0.1128) for 2116 reflections with I > 3tr(/). (VIA) (2-Hydroxy-2-phenylethyl)tri-* Department of Pharmacology. t Department of Inorganic Chemistry. 0108-7681/89/040396-09503.00 methylammonium iodide, C ~HlsNO+. M r = 307.2, monoclinic, No. 14) , a= 5.945(3), b=13.540(6), c=16.182(6) A, fl= 99.42 (3) °, V = 1285 (1) A 3, Z = 4, D x = 1.59 g cm -3, MoKa radiation (2 = 0.71073 A), /l = 24.39 cm -I, F(000) = 608, T= 298 K, R (wR) = 0.0200 (0.0215) for 1801 reflections with I > 3e(/). (VIB) (2-Hydroxy-2-phenylethyl)trimethylammonium iodide, C ~,H ls-NO+.I -, M r = 307.2, orthorhombic, P212~21 (No. 19), a = 5.919 (2), b= 13.775 (9), c= 15.866 (8) A, V= 1294 (1) A 3, Z = 4, D x = 1.58 gcm -3, Mo Ka radiation (2 = 0.71073 A), /z = 24.22 cm -~, F(000) = 608, T= 298 K, R (wR) = 0.0346 (0.0309) for 1207 reflections with I> 3tr(/). (VII) [(3,4-Dihydroxyphenyl)-2-hydroxyethyl]trimethylammonium chloride, C I~H,s-NO~. Mr=247"8, monoclinic, P2~ (No. 4 ), a =6.660(1), b=15.617(2), c=6.079(1)A, /~= 102.83(1) ° , V=616.n(2)A 3, Z=2, Dx= 1.33gem -3, MoKa radiation (2=0.71073A), /1 =3.00cm -1, F(000)=264, T=298K, R (wR)= 0.0459 (0.0486) for 1822 reflections with I > 30(/). (VIII) (3,4-Dihydroxyphenacyl)trimethylammonium chloride methanol solvate, CllH~6NO~.C1-. CH3OH, M r = 277.8, monoclinic, No. 14) , a = 7.735 (1), b = 13.836 (3), c= 13.599 (2)A, /~= 101.77 (1) °, V= 1424.8 (4) A 3, Z= 4, D x = 1.29 g cm -3, Mo K~t radiation (2 = 0.71073 A), /~ = 2.71cm -~, F(000)=592, T=298K, R (wR)= 0.0459 (0.0437) for 1075 reflections with I > 3e(/). (IX) (m-Hydroxyphenylpropyl)trimethylammonium iodide, Cl2H20NO+.l -, Mr= 321.2, monoclinic, P21/a (non-standard, No. 14), a = 11.788 (7), b = 7-722 (4), c=15.266(12)A, fl=96.24(5) ° , V=1381(2)A 3, z=4, D x=l.54gcm -3, MoKs radiation (2= 0.71073 A), /z=22.71 cm -1, F(000)=640, T= 298 K, R (wR) = 0.0638 (0.0644) for 2214 reflections with I > 3tr(/). Synthetic and analytical details have been described for (I), (II), (III) and (IX) [Barlow, Thompson & Scott (1969) . Br. J. Pharmacol. 37, 555-584], (IV) [Barlow, Bowman, Ison & McQueen (1974) . Br. J. Pharmacol. 51, 585-597], (V), (VII) and (VIII) [Armstrong & Barlow (1976). Br. J. Pharmacol. 57, 501-516] , and (VI) [Barlow & Gonzb.lez (1986). Arch. Farmacol. Toxicol. 12, 87-98] . The crystal
Introduction
Catecholamines such as dopamine, noradrenaline and adrenaline are transmitter substances in the sympathetic branch of the peripheral and central nervous systems. Their trimethylammonium salts, however, to varying degrees, activate nicotine-sensitive acetylcholine receptors. The quaternary derivative of dopamine, coryneine, for instance, is particularly active (Barlow, Thompson & Scott, 1969; Barlow, Bowman, Ison & McQueen, 1974) . This paper describes an X-ray crystallographic study of a series of quaternary trimethylammonium compounds and a comparison of their structures with the analogous amines whose crystal structures have been determined as zwitterions or ammonium salts. The compounds are trimethyl-(phenethyl)ammonium iodide (I), (p-hydroxyphenethyl)trimethylammonium iodide [(II), hordenine methiodidel, (m-hydroxyphenethyl)trimethylammonium iodide [(III), leptodactyline iodide], (3,4-dihydroxyphenethyl)trimethylammonium iodide [(IV), coryneine iodide], 2-hydroxy-2-phenylethylamine hydroiodide (V), (2-hydroxy-2-phenylethyl)trimethylammonium iodide [(VIA) and (VIB)], [(3,4-dihydroxyphenyl)-2hydroxyethylltrimethylammonium chloride [(VII), the quaternary trimethylammonium analogue of noradrenaline and adrenaline], (3,4-dihydroxyphenacyl)trimethylammonium chloride [(VIII), the quaternary trimethylammonium analogue of adrenalone] and (mhydroxyphenylpropyl)trimethylammonium iodide (IX). The structural formulae for these nine compounds (together with those for noradrenaline, adrenaline and adrenalone, and three other catecholamines) are given in the scheme below. With the exception of (V) and (IX) the compounds are all (fl-phenylethyl)trimethylammonium iodides or chlorides. They may be hydroxy-substituted at either the meta-and/or para-phenyl positions. The fl-C atom is either unsubstituted, bears a hydroxyl group or is a keto-C atom. Compound (V) is an ammonium salt while (IX) is a (7-phenylpropyl)amine salt.
~H2) --NR2(o, NR3+X" )
Of these, the leptodactyline (III), the (m-hydroxyphenylpropyl)trimethylammonium (IX) and the coryneine (IV) iodides can have marked nicotine-like activity. The quaternary trimethylammonium derivative of adrenalone, (VIII), is also active, whereas that of noradrenaline and, hence, adrenaline, (VII), is only weakly active (Fig. 1) .
The crystal structures were determined to assess the effect of trimethyl substitution at the N atom on the molecular conformation and to see if such a marked change in biological specificity could be explained by a conformational change. The conformation of the phenethylamines is determined by the two torsion angles which fix the position of the N atom relative to the phenyl ring. These determine the distance between the N atom and substituents attached to the ring and to the fl-C atom, parameters commonly discussed in the case of the catecholamines. The symmetrical position with the N atom and the side chain lying in a vertical plane and the ring lying in a horizontal plane (e.g. Fig.  2a ) is not always found for the amines. The expectation is that the bulk associated with a trimethylated quaternary N atom should force the side chain to be both fully extended and in a plane perpendicular to the phenyl ring. Deviations from this conformation in the crystal could arise either from steric interactions (Barlow, Thompson & Scott, 1969) . Asterisks denote that results for compounds (VII) and (VIII) were obtained from tests for nicotine-like activity on guinea-pig ileum, relative to compound (IV) (Barlow, 1987) .
between substituents on the ~C atom and ortho-phenyl H atoms, which seems unlikely unless the fl substituent is large, or, more likely, from intermolecular and crystal-packing effects.
Experimental
Compound (VI) was determined in two crystalline modifications, (VIA) and (VIB). For all ten structure determinations diffraction intensity data were collected on Nicolet four-circle automated diffractometers by 0/20 variable-speed scans [except for (IX) where Wyckoff 09 scans were used]. Table 1 gives the data-collection parameters and Table 2 gives details of data reduction, structure solution and refinement.* Structure solution was usually by heavy-atom and difference Fourier methods, although direct methods were used for the chlorides [(VII) and (VIII)] and DIRDIF (Beurskens et al., 1984) was used to complete the solution of (V). No extinction corrections were applied. Absorption corrections, where applied, were analytical by Gaussian integration between measured crystal faces. Structures were refined by blockedcascade least squares on a Data General Desktop minicomputer with the SHELXTL (Sheldrick, 1981) package, or, in the case of (III), by full-matrix least squares on a Digital MicroVAX II computer with the SHELXTL-PIus (Sheldrick, 1988 , for Nicolet Instrument Corporation) package. Unless stated explicitly below, the following procedure was adopted for the structure refinements. All non-H atoms were refined with anisotropic thermal parameters. The phenyl rings were refined as regular hexagons (C-C 1.395/~). Nonhydroxyl H atoms were incorporated at geometrically idealized positions (C-H 0.96/~, fixed Uiso of 1.2Ueq of C) and refined by a riding model. Hydroxyl H atoms were located from difference Fourier maps (usually low-angle, sin0/2 < 0.25). Any large positive peaks (> 1 e/~-3) in the final AT' maps were only found close to iodine. The function minimized during refinement was ~w(F o -IFcl) 2, where w-l= [a2(F) + gF 2] and values of g are given in Table 2 . Atomic scattering factors and corrections for anomalous dispersion were taken from International Tables for X-ray Crystallography (1974) .
Structure refinement
The structure refinement details of compounds (I) to (VI) and compound (VIII) are as follows: Compound * A table summarizing the crystal data for the nine compounds, and lists of structure factors, bond lengths and interbond angles, anisotropic thermal parameters and H-atom parameters have been deposited with the British Library Document Supply Centre as Supplementary Publication No. SUP 51665 (216 pp.). Copies may be obtained through The Executive Secretary, International Union of Crystallography, 5 Abbey Square, Chester CH 1 2HU, England.
(I), phenyl was freely refined. Compound (II), which has two molecules per asymmetric unit, phenyls also were freely refined. Compound (III), iodine lies close to the mirror plane at x = 0.5; the rest of the structure from AF map together with 'ghost' image. High correlations were found during least-squares refinement, and poor molecular geometry. NC 4 end of the molecule was fixed as tetrahedral. All non-H atoms except iodine were isotropically refined. Hydroxyl and water H atoms were not located. Damped full-matrix least-squares refinement. Compound (IV), phenyl was freely refined. Compound (V), we were unable to solve the structure from data collected from one of many thin plates. The thicker crystal used here was probably a monoclinic twin (as unit-cell-determining reflections if not carefully scrutinized on the diffractometer gave poor orthorhombic cell parameters in the least-squares I . . . . . 
Results
Table 3 lists the non-H-atom coordinates and equivalent isotropic thermal parameters for compounds (I)-(IX). Table 4 defines and lists the values of the torsion angles which determine the conformation of the side chain, and gives the intramolecular distances from the N atom to the phenyl-ring centroid (N.RNG) and to the metaand para-hydroxyl 0 atoms (N.m-O and N.p-O, respectively). In addition to the results for compounds (I)-(VIII) determined in this paper, Table 4 includes results for the analogous amines and/or ammonium compounds for comparison. Coordinates for published structures were retrieved from Version 3.20 of the Cambridge Structural Database (Allen et al., 1979) and derived structural parameters for these structures were calculated using the program GEOM78 (Murray-Rust & Motherwell, 1978) . Compounds retrieved and used for comparison in this and other tables are referred to by their unique CSD reference code. (5) --288 (11) C(4) 1107 (12) C(3) 3056 (12) C(2) 3571 (9) C(1) 2152 (8) C (7) 2717 (9) C(8) 4248 (7) C(9) 6686 (8) C(10) 3359 (8) C(ll) 6463 (9) I 1220 (1) Compound (II) I(1) 1681 (1) C(1) 2925 (5) C(2) 4317 (5) C(3) 4680 (5) C(4) 3640 (4) 0(4) 4049 (4) C(5) 2228 (5) C(6) 1887 (5) C (7) 2555 (6) C(8) 2663 (5) N(1) 2386 (4) C(9) 987 (5) C(10) 3518 (5) C(ll) 2355 (9) I(1') 8546 (1) C(l') 6824 (4) C(2') 7302 (5) C(3') 7409 (5) C(4') 7049 (5) O(4') 7083 (5) C(5') 6600 (6) C(6') 6490 (5) C(7') 6694 (5) c(8') 8088 (4) N(I') 8172 (4) C(9') 7032 (5) C(10') 9594 (5) C(11') 8057 (6) Compound (III) I(1) 5200 (1) C(2) 7641 (9) C(3) 8896 C(4) 10557 C(5) 10964 C(6) 9709 C(l) 8047 0(5) 12594 (12) C(7)
6687 (17) (7) 50 (2) 4631 (8) -560 (2) 71 (2) C(5) 1714 (3) 9748 (3) 6016 (6) 41 (1) 5469 (8) -452 (2) 68 (2) 0(5) 2178 (3) 9908 (2) 7984 (4) 65 (1) 5912 (7) 36 (2) 53 (1) C(4) 1998 (3) 10192 (2) 4467 (6) 38 (1) 5498 (7) 428 (2) 45 (I) 0(4) 2756 (2) 10808 (2) 5042 (4) 55 (1) 6019 (8) 970 (2) 58 (2) C (3) 1523 (3) 10007 (3) 2497 (6) 47 (1) 4690 (7) 1185 (2) 43 (1) C (2) 748 (3) 9384 (3) 2065 (7) 50 (1) 3616 (7) 1836 (2) 52 (2) C (7) -471 (4) 8336 (3) 3088 (9) 63 (2) 5199 (7) 2096 (2) 48 (1) C(8) -106 (3) 7427 (3) 3348 (7) 44 (1) 6760 (7) 1716 (2) 51 (1) N -988 (3) 6775 (2) 2908 (6) 48 (1) 277 (1) 1802 (1) 44 (1) C(9) -1736 (4) 6928 (4) 4208 (10) 81 (3) C(10) -491 (4) 5919 (3) 3347 (9) 72 (2) C(11) -1540 (4) 6789 (4) 758 (8) 74 (2) 2287 (1) 4175 (1) 63 (1) 971 (4) 8580 (3) 46 (l) 1069 (4) 8421 (3) 50 (1) 1126 (5) 7506 (3) 54 (2) 1101 (4) 6737 (3) 45 (1) 1147 (4) 5854 (2) 64 (1) 1032 (4) 6884 (3) 50 (1) 960 (4) 7796 (3) 51 (1) 890 (4) 9579 (3) 58 (2) (7) 53 (2) 1393 (14) 7939 (7) 66 (2) 1153 (13) 6740 (7) 64 (2) (8) 74 (1) C(10) -1639 (5) 5539 (2) -2290 (7) 63 (I) C(l 1) -2850 (7) 4252 (4) -4296 (7) 93 (2) Compound ( (2) 51 (1) 0(5) 1412 (4) 1258 (2) 1631 (2) 48 (1) C (7) 2821 (5) -649 (3) -I110 (3) 39 (2) 0(7) 2750 (4) 
Discussion
All structures in Table 4 have the side chain in the approximately fully extended trans conformation (TOR2, torsion angle 1-7-8--9) leading to similarity among the N-atom-to-phenyl-centroid distances (N.RNG) with values from 5.088 to 5.237 A and in the N-atom-to-para-O-atom distances (N.p-O) having values from 7.719 to 7.938/~. Variations in the angle TOR1 (2--1-7--8) (and hence TOR3, the improper torsion angle 2-1-7-9) which corresponds to rotation of the phenyl group about the C 1-C7 bond (Table 4) necessarily cause variations in the N-atom-to-meta-O-atom distances (N.m-O from 6.607 to 7.409 A) and change the appearance of the molecules when viewed edge-on (Fig. 2) . The orientation of the side chain with respect to the phenyl ring is depicted schematically in Fig. 3 (where the plane of the phenyl ring is drawn as a horizontal line and the projections of TOR1 and TOR3 are drawn). Comparison of PEAHCL and TYRAMC with their corresponding trimethylammonium iodides [(I) and (II), respectively] shows the expected effect of trimethyl substitution, namely, to make the side chain more perpendicular to the phenyl-ring plane. The position for neutral tyramine (TYRAMH) is intermediate (Table 4) .
With leptodactyline (III) and the phenylpropyl compound (IX) the m-hydroxyl group and the N atom are anti [TOR3 of 105 ° in (III) and TOR4 of 128 ° in (IX)] while with coryneine (IV) and dopamine (DOPAMN01) these groups are syn (TOR3 of 76 and 84 ° , respectively). It is interesting to note that in 5-hydroxydopamine, HDOPAC, (which has two metahydroxyl groups) the angles TOR1 (59 °) and, hence, TOR3 (49.7 ° ) are at the minimum of the range observed for the non-keto-type compounds. When HDOPAC is trimethylated at the ring hydroxyls to give mescaline (MESCAL) the side chain adopts a more nearly perpendicular orientation with respect to the phenyl ring (TOR1 and TOR3 are 88.5 and 92.5 °, respectively). While this might be expected for mescaline on grounds of steric interaction, the conformation of 5-hydroxydopamine is not that expected and is possibly a result of crystal-packing forces.
The effect of trimethyl substitution on the fl-hydroxy compounds would appear to be minimal, comparing compound (V) on the one hand with (VIA) and (VIB) on the other (Fig. 3) , but causes a twist away from perpendicular in the case of adrenaline [ADRENL vs (VII)]. The meta-and fl-hydroxyl groups are syn in NADRHC, compound (VII), and the second molecule of ISOPROT20 [the improper m-O...C-C-O(H) torsion angles defined by atoms 11-1-7-10 (Table 4 ) lie in the range 24.9 to 44.1°], while they are anti in ADRENL (neutral), NADREN (neutral) and the first molecule of ISOPROT20 [m-O...C-C-O(H) torsion angles in the range 143.8 to 163.2°].
In the ketones, trimethyl substitution has little effect with the side chain lying close to the plane of the phenyl ring and the meta-hydroxyl and the keto group mutually cisoid; the torsion angle CC-C=O (Table 4) is -4.075 and 8.08 ° for ADRENC and (VIII), respectively. The keto group and N atom are also cisoid (O=C-CN in Table 4 ).
The phenylpropyl compound (IX) has a near fully extended side chain (TOR2 of--165.8 ° and TOR3 of --179.1 °) with an N.RNG distance of 6.34 A and an N.m--O distance of 8.39A. The side chain is not perpendicular to the phenyl-ring plane, the N-atom being anti to the meta-hydroxyl group (TOR1 is 136.1 ° and the improper TOR4 is 128.3°). The 
(o)
TOR 1 is the angle 2-1-7-8. TOR2 is the angle 1-7-8-9. TOR3 is the improper torsion angle 2-1-7-9 [TOR4 in (IX) is the analogous torsion angle 2-1-7-N÷]. O=C-CN is the torsion angle 10-7-8-9 in the ketones. CC-C=O is the torsion angle 2-1-7-10 in the ketones. conformation of both the phenethylamine (III) and the (phenylpropyl)amine (IX) trimethylammmonium quaternaries shows some similarity to that of nicotine monohydrogen iodide (Barlow, Howard & Johnson, 1986) . In nicotine monohydrogen iodide the torsion angle relating the pyrrolidine N atom via the ringjoining bond, to the plane of the pyridine ring (119°), is intermediate between the improper torsion angle TOR3 in compound (III) (105 °) and TOR4 in compound (IX) (136°). This similarity can be envisaged by the superposition of nicotine monohydrogen iodide and compound (IX), depicted in Fig. 4 , where the smaller angle (16 ° ) is found between the planes of the six-membered rings. As it would appear to be the monoprotonated form of nicotine which is acting at the neuromuscular junction (Barlow & Hamilton, 1962) this conformational similarity may begin to explain the enhanced activity of compounds (III) and (IX) relative to nicotine (Fig. 1) . However, compound (IV) which has TOR3 = 76 ° and also shows enhanced activity is conformationally less like nicotine monohydrogen iodide than either (III) or (IX).
Concluding remarks
It is difficult to come to any firm conclusion about the relationships between conformation and biological activity when dealing with agonists. Because they produce a response from the tissue, their activity depends upon ability to activate receptors (efficacy) as well as ability to become bound to them (affinity). Some ideas may be obtained, however, by considering the relative activities of enantiomers. With catecholamines acting at adrenergic receptors there is a marked difference between the activity of (-)-and (+)-enantiomers, suggesting that there are interactions of at least three groups in the drug with groups in the receptor. The interacting groups in the catecholamines appear to be the amino group, the recta-phenolic group and the fl-hydroxyl group.
With actions at nicotinic receptors there is also some degree of stereospecificity. Natural (-)-nicotine is more active than (+)-nicotine, though the degree of stereospecificity is not as large as that found for the catecholamines at adrenergic receptors and is different for different types of nicotinic receptor (Barlow & Hamilton, 1965) . A charged N atom appears to be important for nicotine-like activity (Barlow & Hamilton, 1962) but it is not easy to identify two other groups which might be involved in a three-point interaction at the receptor site. One such group might be a meta-phenolic group but its position relative to the N atom varies considerably from one compound to another and even compounds without it, such as phenethyltrimethylammonium salts, are not inactive.
The structures of the compounds determined here suggest that instead of a three-point interaction between drug and nicotinic receptor, the interaction might involve one point (the charged N atom) and a region of planarity in the molecule (the aromatic ring) without specifying particular groups in the plane. Although such small molecules would be expected to be conformationally quite flexible in solution, an energetic preference for one conformer may make it easier for some molecules to interact rather than others. The favourable disposition of a charged N atom relative to an aromatic ring has been encountered in the structure of the conformationally restricted alkaloid (-)-cytisine (Barlow & Johnson, 1988) which shows nicotine-like biological activity (Dale & Laidlaw, 1912; Barlow & McLeod, 1969) .
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